Tag: F-star Therapeutics
F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated...